Sign in or Register   Sign in or Register
  |  

Mouse Anti-LCK Recombinant Antibody (3A5) (CBMAB-P0461-YC)

Provided herein is a Mouse monoclonal antibody against Mouse LCK proto-oncogene, Src family tyrosine kinase. The antibody can be used for immunoassay techniques, such as FuncS, IP, WB.
See all LCK antibodies
Published Data
Fig.1 Confocal microscopy of CAR.OTI cells in conjugation with MC57 target cells via TCR, labeled with anti-Lck (green).
...View More
Fig.2 OTI CTLs cocultured with parental, OVA257-, or HER2-expressing MC57 targets and Western blotting performed for pLck.
...View More

Summary

Host Animal
Mouse
Specificity
Mouse
Clone
3A5
Antibody Isotype
IgG2b, κ
Application
FuncS, IP, WB

Basic Information

Specificity
Mouse
Antibody Isotype
IgG2b, κ
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
10 mM PBS, pH 7.4, with 0.2% BSA and 0.09% sodium azide
Storage
Store at 4°C short term (1-2 weeks). Aliquot and store at-20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
LCK
Introduction
LCK is a member of the Src family of protein tyrosine kinases (PTKs). The encoded protein is a key signaling molecule in the selection and maturation of developing T-cells. It contains N-terminal sites for myristylation and palmitylation, a PTK domain, and SH2 and SH3 domains which are involved in mediating protein-protein interactions with phosphotyrosine-containing and proline-rich motifs, respectively. The protein localizes to the plasma membrane and pericentrosomal vesicles, and binds to cell surface receptors, including CD4 and CD8, and other signaling molecules.
Entrez Gene ID
16818
UniProt ID
P06240
Alternative Names
IMD22; LSK; YT16; p56lck; pp58lck
Function
Non-receptor tyrosine-protein kinase that plays an essential role in the selection and maturation of developing T-cells in the thymus and in the function of mature T-cells. Plays a key role in T-cell antigen receptor (TCR)-linked signal transduction pathways. Constitutively associated with the cytoplasmic portions of the CD4 and CD8 surface receptors. Association of the TCR with a peptide antigen-bound MHC complex facilitates the interaction of CD4 and CD8 with MHC class II and class I molecules, respectively, thereby recruiting the associated LCK protein to the vicinity of the TCR/CD3 complex. LCK then phosphorylates tyrosine residues within the immunoreceptor tyrosine-based activation motifs (ITAM) of the cytoplasmic tails of the TCR-gamma chains and CD3 subunits, initiating the TCR/CD3 signaling pathway. Once stimulated, the TCR recruits the tyrosine kinase ZAP70, that becomes phosphorylated and activated by LCK. Following this, a large number of signaling molecules are recruited, ultimately leading to lymphokine production. LCK also contributes to signaling by other receptor molecules. Associates directly with the cytoplasmic tail of CD2, which leads to hyperphosphorylation and activation of LCK. Also plays a role in the IL2 receptor-linked signaling pathway that controls the T-cell proliferative response. Binding of IL2 to its receptor results in increased activity of LCK. Is expressed at all stages of thymocyte development and is required for the regulation of maturation events that are governed by both pre-TCR and mature alpha beta TCR. Phosphorylates other substrates including RUNX3, PTK2B/PYK2, the microtubule-associated protein MAPT, RHOH or TYROBP. Interacts with FYB2 (PubMed:27335501).
Biological Process
Activation of cysteine-type endopeptidase activity involved in apoptotic processManual Assertion Based On ExperimentIDA:UniProtKB
B cell receptor signaling pathwayManual Assertion Based On ExperimentIBA:GO_Central
Cell differentiationManual Assertion Based On ExperimentIBA:GO_Central
Cellular zinc ion homeostasisManual Assertion Based On ExperimentIEP:UniProtKB
Hemopoiesis1 PublicationNAS:UniProtKB
Innate immune responseManual Assertion Based On ExperimentIBA:GO_Central
Intracellular signal transductionManual Assertion Based On ExperimentIDA:ARUK-UCL
Leukocyte migrationTAS:Reactome
Peptidyl-tyrosine phosphorylationManual Assertion Based On ExperimentIMP:ARUK-UCL
Platelet activationTAS:Reactome
Positive regulation of heterotypic cell-cell adhesionManual Assertion Based On ExperimentIMP:BHF-UCL
Positive regulation of intrinsic apoptotic signaling pathwayManual Assertion Based On ExperimentIMP:UniProtKB
Positive regulation of leukocyte cell-cell adhesionManual Assertion Based On ExperimentIMP:BHF-UCL
Positive regulation of T cell activationManual Assertion Based On ExperimentIDA:UniProtKB
Positive regulation of T cell receptor signaling pathway1 PublicationNAS:UniProtKB
Protein phosphorylationManual Assertion Based On ExperimentIDA:UniProtKB
Regulation of lymphocyte activation1 PublicationNAS:UniProtKB
Release of sequestered calcium ion into cytosolISS:UniProtKB
Response to xenobiotic stimulusManual Assertion Based On ExperimentIDA:UniProtKB
T cell costimulationTAS:Reactome
T cell differentiationManual Assertion Based On ExperimentIMP:UniProtKB
T cell receptor signaling pathwayTAS:Reactome
Transmembrane receptor protein tyrosine kinase signaling pathwayManual Assertion Based On ExperimentIBA:GO_Central
Cellular Location
Cell membrane
Cytoplasm, cytosol
Present in lipid rafts in an inactive form.
Involvement in disease
A chromosomal aberration involving LCK is found in leukemias. Translocation t(1;7)(p34;q34) with TCRB.
Immunodeficiency 22 (IMD22):
A primary immunodeficiency characterized by T-cell dysfunction. Affected individuals present with lymphopenia, recurrent infections, severe diarrhea, and failure to thrive.
PTM
Autophosphorylated on Tyr-394, increasing enzymatic activity, this site is dephosphorylated by PTN22. Phosphorylated on Tyr-505 by CSK, decreasing activity. Dephosphorylated by PTPRC/CD45. Dephosphorylation at Tyr-394 by PTPN2 negatively regulates T-cell receptor signaling.
Myristoylation is required prior to palmitoylation.
Palmitoylation regulates association with the plasma membrane and could be mediated by ZDHHC2.

Conboy, C. B., Yonkus, J. A., Buckarma, E. H., Mun, D. G., Werneburg, N. W., Watkins, R. D., ... & Smoot, R. L. (2023). LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma. Journal of hepatology, 78(1), 142-152.

Premanand, A., & Reena Rajkumari, B. (2023). Bioinformatic analysis of gene expression data reveals Src family protein tyrosine kinases as key players in androgenetic alopecia. Frontiers in Medicine, 10, 1108358.

Bagnato, G., Leopizzi, M., Urciuoli, E., & Peruzzi, B. (2020). Nuclear functions of the tyrosine kinase Src. International Journal of Molecular Sciences, 21(8), 2675.

Sirvent, A., Mevizou, R., Naim, D., Lafitte, M., & Roche, S. (2020). Src family tyrosine kinases in intestinal homeostasis, regeneration and tumorigenesis. Cancers, 12(8), 2014.

Simatou, A., Simatos, G., Goulielmaki, M., Spandidos, D. A., Baliou, S., & Zoumpourlis, V. (2020). Historical retrospective of the SRC oncogene and new perspectives. Molecular and clinical oncology, 13(4), 1-1.

Martellucci, S., Clementi, L., Sabetta, S., Mattei, V., Botta, L., & Angelucci, A. (2020). Src family kinases as therapeutic targets in advanced solid tumors: what we have learned so far. Cancers, 12(6), 1448.

Andersen, T. C. B., Kristiansen, P. E., Huszenicza, Z., Johansson, M. U., Gopalakrishnan, R. P., Kjelstrup, H., ... & Spurkland, A. (2019). The SH3 domains of the protein kinases ITK and LCK compete for adjacent sites on T cell–specific adapter protein. Journal of Biological Chemistry, 294(42), 15480-15494.

Cooper, J. A. (2018). The src family of protein-tyrosine kinases. In Peptides and protein phosphorylation (pp. 85-113). CRC Press.

Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-LCK Recombinant Antibody (3A5)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare